Compare, Analyse GSK Pharma with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results

GSK PHARMA     Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 GSK PHARMA   ADCOCK INGRAM
EQUITY SHARE DATA
    GSK PHARMA
Mar-19
ADCOCK INGRAM
Jun-14
GSK PHARMA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs3,595353-   
Low Rs1,253255-   
Sales per share (Unadj.) Rs184.7105.0-  
Earnings per share (Unadj.) Rs26.3-26.5-  
Cash flow per share (Unadj.) Rs29.2-21.9-  
Dividends per share (Unadj.) Rs20.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs126.382.4-  
Shares outstanding (eoy) m169.40168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x13.12.9 453.7%   
Avg P/E ratio x92.2-11.5 -802.9%  
P/CF ratio (eoy) x83.1-13.9 -599.9%  
Price / Book Value ratio x19.23.7 520.6%  
Dividend payout %76.10-   
Avg Mkt Cap Rs m410,62651,290 800.6%   
No. of employees `0005.04.3 115.5%   
Total wages/salary Rs m5,3723,219 166.9%   
Avg. sales/employee Rs Th6,306.74,129.2 152.7%   
Avg. wages/employee Rs Th1,083.1749.8 144.4%   
Avg. net profit/employee Rs Th898.0-1,040.5 -86.3%   
INCOME DATA
Net Sales Rs m31,28117,727 176.5%  
Other income Rs m1,023124 824.2%   
Total revenues Rs m32,30417,851 181.0%   
Gross profit Rs m6,009-3,072 -195.6%  
Depreciation Rs m486765 63.5%   
Interest Rs m6480 1.2%   
Profit before tax Rs m6,540-4,193 -156.0%   
Minority Interest Rs m0-12 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m2870-   
Tax Rs m2,373262 905.7%   
Profit after tax Rs m4,454-4,467 -99.7%  
Gross profit margin %19.2-17.3 -110.8%  
Effective tax rate %36.3-6.2 -580.7%   
Net profit margin %14.2-25.2 -56.5%  
BALANCE SHEET DATA
Current assets Rs m20,06112,983 154.5%   
Current liabilities Rs m14,5437,305 199.1%   
Net working cap to sales %17.632.0 55.1%  
Current ratio x1.41.8 77.6%  
Inventory Days Days57111 51.2%  
Debtors Days Days14124 11.3%  
Net fixed assets Rs m14,3437,568 189.5%   
Share capital Rs m1,69482 2,058.2%   
"Free" reserves Rs m19,7040-   
Net worth Rs m21,39813,914 153.8%   
Long term debt Rs m24,889 0.0%   
Total assets Rs m39,11326,284 148.8%  
Interest coverage x1,091.0-7.7 -14,109.7%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.80.7 118.6%   
Return on assets %11.4-15.2 -75.2%  
Return on equity %20.8-32.1 -64.8%  
Return on capital %31.9-19.8 -161.2%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m-6,5570-   
CASH FLOW
From Operations Rs m3,9941,513 263.9%  
From Investments Rs m-1,433-465 308.5%  
From Financial Activity Rs m-3,5844,438 -80.8%  
Net Cashflow Rs m-1,0235,486 -18.7%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.87 Rs / ZAR

Compare GSK PHARMA With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare GSK PHARMA With: SANOFI INDIA  FRESENIUS KABI ONCO.  ALKEM LABORATORIES  FDC  ABBOTT INDIA  



Today's Market

Crucial Week Ahead for the Indian Stock Market(Momentum Moves)

The market scaled new life-time highs this week but it was the bears who took control. The benchmark indices, Sensex and Nifty ended mostly flat for the week but the momentum was in favour of the bears.

Related Views On News

GSK PHARMA Announces Quarterly Results (2QFY21); Net Profit Down 84.8% (Quarterly Result Update)

Oct 30, 2020 | Updated on Oct 30, 2020

For the quarter ended September 2020, GSK PHARMA has posted a net profit of Rs 765 m (down 84.8% YoY). Sales on the other hand came in at Rs 9 bn (down 0.3% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

GSK PHARMA Announces Quarterly Results (1QFY21); Net Profit Down 2.2% (Quarterly Result Update)

Aug 26, 2020 | Updated on Aug 26, 2020

For the quarter ended June 2020, GSK PHARMA has posted a net profit of Rs 1 bn (down 2.2% YoY). Sales on the other hand came in at Rs 6 bn (down 17.7% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

GSK PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 24, 2019 | Updated on Jun 24, 2019

Here's an analysis of the annual report of GSK PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of GSK PHARMA. Also includes updates on the valuation of GSK PHARMA.

More Views on News

Most Popular

Why Gold Hit Lower Circuit (Fast Profits Daily)

Jan 11, 2021

Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...

Time to Book Profits in Pharma Stocks (Fast Profits Daily)

Jan 15, 2021

In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.

A Rare Chance to Invest in Potential Multibaggers in 2021 (Profit Hunter)

Jan 11, 2021

Our ace stock picker is ready to capitalise on a big growth opportunity.

Smallcap Stocks: Your Best Bet for 2021 and Beyond (Profit Hunter)

Jan 15, 2021

The pandemic failed to thwart Richa's investing success formula for 2020.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

GSK PHARMA SHARE PRICE


Jan 22, 2021 (Close)

TRACK GSK PHARMA

  • Track your investment in GSK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON GSK PHARMA

GSK PHARMA 5-YR ANALYSIS

COMPARE GSK PHARMA WITH

FEATURED VIDEOS

Great vs Good: Which Stock Will Win in 2021?

Safest Assets in 2021 are Not What You Think...

I Combined Stocks & Gold and Saw the Magic Happen

Stocks Could Do Extremely Well, But...

More Featured Videos

MARKET STATS